Description
AMBLE · RESEARCH PRODUCT INFORMATION
Product overview
This source-listed blend combines BPC-157 5mg and TB-500 5mg, with mannitol, in one vial. Research on either component alone does not establish the properties, safety or effectiveness of the combined formulation. Verify the exact component identities and lot documentation before laboratory use.
For scientific research and development only. Intended for in-vitro laboratory work, not human or animal administration. Not for use as a medicine, diagnostic product, medical device, food, supplement or cosmetic. No dosing, injection or treatment instructions are provided.
Product specifications
| Quantity | 10 mg |
|---|---|
| Unit | 1 Vial |
| Salt form | Acetate |
| Supplier reference purity (not lot verification) | ≥99% |
| Source-listed laboratory solvents | Sterile / Bacteriostatic water |
| Product Type | Blend |
| Excipient named by supplier | Mannitol; amount not specified in the source specification table |
| Source-listed blend components | BPC-157 5mg + TB-500 5mg |
Product features
- Source-listed pack: 10 mg 1 Vial
- Source-listed presentation: Not stated in source table
- Excipient: Mannitol; amount not specified in the source specification table
These characteristics identify the supplier reference presentation. They are not independent testing or verification of the current Amble lot.
These are reference specifications reported on the corresponding Particle Peptides page, not independent analytical verification of an Amble lot. Confirm the received label, identity, formulation and batch documentation before laboratory use. Unlisted fields have not been invented.
Storage and handling
1. Research use and restrictions
For scientific research and development only. Intended for in-vitro laboratory work, not human or animal administration. Not for use as a medicine, diagnostic product, medical device, food, supplement or cosmetic. No dosing, injection or treatment instructions are provided.
Literature involving animals or clinical studies is background information only and does not authorize this product for those uses. Do not supply this material for human investigational use.
2. Peptides in transport
Follow the current product label and lot-specific transport documentation. A general supplier statement about transport stability is not a guarantee for every formulation, liquid, blend or Amble shipment. The source supplier lists shipping restrictions for: Canada, Croatia, Czech Republic, Iceland, Ireland, Italy, Luxemburg, Norway, Serbia, South Africa, Switzerland. This is the supplier’s published list, not a complete legal assessment or a replacement for Amble’s shipping policy.
3. Storage of lyophilized peptides
The supplier gives general guidance to protect lyophilized peptides from light and moisture. Storage temperature and expiry must follow the actual formulation and lot documentation. Do not treat a generic storage-duration table as validated shelf-life data for this Amble product.
4. Storage of reconstituted peptides
Solution stability depends on sequence, formulation, solvent and handling. Use product-specific stability documentation and laboratory procedures rather than assuming the same refrigerated life for all peptides. The supplier’s Ipamorelin stability discussion cannot be extrapolated to other products without supporting data.
5. Storage of peptide solutions
Avoid unnecessary freeze–thaw cycling and follow the documented conditions for the exact solution. This page does not establish a validated shelf life after preparation. The listed solvent information is a supplier reference, not a patient-use or injection protocol.
Overview of published research
The corresponding source page discusses the topics below. They describe areas of investigation, not proven customer benefits, treatment indications or evidence that this particular Amble batch has been tested.
- Component-specific tissue-response research
- Cell migration and vascular-signaling models
- Blend identity, composition and formulation-specific evidence
The source blend page does not provide a product-specific bibliography. Evidence concerning BPC-157 or thymosin beta-4 individually must not be represented as testing of this exact blend.
Quality and documentation
Source attribution: the specifications and bibliography below refer to Particle Peptides. Amble branding does not turn the supplier’s studies or documents into Amble batch certifications.
View the corresponding supplier product page
Document links are retained as supplier references. Confirm lot matching, document authenticity and applicability before relying on them; this update does not independently verify those documents.
No product-specific bibliography was present in the corresponding source description; references have not been invented.
Product questions and answers
What is BPC-157 + TB-500 Blend 5mg / 5mg with Mannitol?
This source-listed blend combines BPC-157 5mg and TB-500 5mg, with mannitol, in one vial. Research on either component alone does not establish the properties, safety or effectiveness of the combined formulation. Verify the exact component identities and lot documentation before laboratory use.
What quantity is listed for BPC-157 + TB-500 5mg/5mg Blend?
The corresponding supplier reference lists 10 mg 1 Vial. This applies to the stated presentation only; other strengths and quantities are not included.
Which identity or formulation details matter for BPC-157 + TB-500 5mg/5mg Blend?
The source lists BPC-157 5mg plus TB-500 5mg with mannitol. Studies of a component alone do not verify this combined formulation or establish clinical suitability.
Does the linked documentation certify this Amble batch?
No Amble-lot certification is established by a supplier webpage or an unmatched COA. Confirm the laboratory report, exact batch number, identity and formulation before relying on the documentation.
What storage conditions are verified for BPC-157 + TB-500 5mg/5mg Blend?
Follow the actual lot label and product-specific safety and stability documentation. Generic storage tables and studies on another peptide do not establish this product’s shelf life.
Is BPC-157 + TB-500 5mg/5mg Blend intended for human use?
No. This is a research-use listing for in-vitro laboratory work, not human or animal administration. The page provides no dosing, injection or treatment instructions.
US online ordering information
Information for customers reviewing BPC-157 + TB-500 5mg/5mg Blend online from the United States.
This is a research-use listing, not a patient treatment or a finished medicine. Do not use it for human or animal administration. Review the exact formulation and lot-matched documentation, and confirm jurisdiction-specific eligibility before placing any order.
Use the live price and stock display on this page and review the final checkout total. Delivery, tax and return conditions depend on the product and destination; do not assume a delivery date or eligibility from this page alone.
For product or ordering questions, email hello@joinamblehealth.com. Read the Amble terms of service or visit your Amble account.
Reviews
There are no reviews yet.